NCT05971615

Brief Summary

concordance between the lactate values on peripheral venous and arterial blood gases in all patients receiving an arterial sample on their arrival in the S.A.U.V.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2020

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 18, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 18, 2020

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

May 23, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 2, 2023

Completed
Last Updated

August 2, 2023

Status Verified

July 1, 2023

Enrollment Period

11 months

First QC Date

May 23, 2023

Last Update Submit

July 25, 2023

Conditions

Critical Illness

Outcome Measures

Primary Outcomes (1)

  • lactates on peripheral venous and arterial blood gases

    mmol/L

    baseline

Study Arms (1)

Peripheral Venous Blood Gases

OTHER
Other: peripheral venous blood gases

Interventions

peripheral venous blood gasesOTHER

peripheral venous blood gases

Peripheral Venous Blood Gases

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • one of this condition in emergency unit :
  • acute respiratory distress
  • a suspicion of an acid-base disorder
  • a state of shock
  • Pathologies requiring monitoring of the respiratory system
  • Patient under NIV
  • Poisoning
  • Coma with a Glasgow score \< or equal to 8

You may not qualify if:

  • Patient presenting another pathology supported in SAUV not requiring the realization of arterial blood gases
  • Patient aged \< 18 years
  • Pregnant or breastfeeding woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CAEN University Hospital

Caen, France

Location

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 23, 2023

First Posted

August 2, 2023

Study Start

January 15, 2020

Primary Completion

December 18, 2020

Study Completion

December 18, 2020

Last Updated

August 2, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations

FR(1)